Turn Therapeutics Q1 EPS $(0.03) Misses $(0.02) Estimate
Benzinga Newsdesk 5 months ago
EarningsEarnings MissesNews
Turn Therapeutics (NASDAQ:TTRX) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 200 percent decrease over losses of $(0.01) per share from
Turn Therapeutics (NASDAQ:TTRX) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 200 percent decrease over losses of $(0.01) per share from the same period last year.